Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Open-market sale Chief Financial Officer sold 1,995 shares at $17.49 ($34,896)
  2. 8-K Event Executive or director change · Bylaws or fiscal year change
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 4 Open-market sale Chief Operating Officer sold 3,217 shares at $17.89 ($57,556)
  6. 4 Open-market sale Chief Financial Officer sold 6,144 shares at $19.00 ($116,736)
  7. SC 13G Stake Amended Statement of Ownership
  8. 4 Other disposition Director disposed of 950,000 shares (other)
  9. 4 Open-market sale Chief Operating Officer sold 5,000 shares at $18.84 ($94,216)
  10. 4 Other disposition Director disposed of 983,221 shares (other)
  11. 4 Open-market sale Chief Operating Officer sold 5,000 shares at $19.37 ($96,851)
  12. 8-K Event Executive or director change
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Chief Operating Officer sold 15,000 shares at $18.25 ($273,687)
  18. 4 Option exercise President & CEO acquired 29,994 shares (option exercise)
  19. 4 Open-market sale Director sold 54,997 shares at $17.58 ($966,759)
  20. 4 Open-market sale Chief Operating Officer sold 2,500 shares at $17.22 ($43,050)

Page 21 of 47 · 923 filings